Emergency department screening and outpatient follow-up for new diabetes
Official title: Identifying Risk Factors for Poor Glycemic Control Among Emergency Department Patients and Improving Linkage to Outpatient Care
Run by NYU Langone Health · NCT05899023 · Data updated 2026-11-12
This project will test whether telehealth bridge visits help emergency department patients newly diagnosed with diabetes (HbA1c ≥ 6.5%) connect to outpatient primary care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 70 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | December 1, 2025 |
| Main results expected | May 31, 2028 |
| Study ends | May 31, 2028 |
| Registry record updated | May 19, 2026 |
| Trial ID | NCT05899023 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are ED patients with an initial HbA1c ≥ 6.5% who are newly diagnosed, live in New York City or Long Island, speak English or Spanish, and can provide informed consent.
✕Probably not a fit
Patients who already have established diabetes care, live outside the study area, cannot use telehealth, or have medical conditions that make HbA1c unreliable (e.g., sickle cell disease, recent significant blood loss) are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This NIH-funded R01 at NYU Langone combines retrospective chart review, qualitative interviews, and a randomized controlled trial to improve follow-up after a new diabetes diagnosis in the ED. First, investigators will analyze past ED records to identify factors linked to failure to obtain outpatient care. Second, they will conduct interviews with patients who did not follow up to understand barriers to care. Finally, they will randomize eligible patients to a telehealth bridge visit versus standard care to measure whether telehealth improves linkage to primary care.
Why it matters
Potential benefit: If successful, the intervention could increase timely linkage to outpatient care, accelerate treatment initiation, and reduce early complications from uncontrolled diabetes.
How similar studies have gone: Previous research supports telehealth for improving outpatient follow-up and care coordination in other settings, but randomized trials specifically linking ED-diagnosed diabetes patients to primary care are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Emergency patient receiving lab tests with an initial HbA1c test result of ≥ 6.5% * Residential address in New York City or Long Island * Primary language is English or Spanish * Able to provide informed consent Exclusion Criteria: * No prior history of diabetes * No medical condition that would result in a spurious HbA1c test (e.g., sickle cell, recent blood loss)
Where it's running
-
NYU Langone Health
New York, New York, United States Recruiting
Study contacts
- Principal investigator: David C. Lee — NYU Langone Health
- Study coordinator: David C. Lee
- Email: David.Lee@nyulangone.org
- Phone: 212-562-6561
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preventing lower limb artery disease in adults with diabetes using a risk-prediction model and HAPA-based nursing
A risk-prediction model is tested in adults with type 2 diabetes to see if a nursing plan based on the HAPA model can reduce peripheral artery disease in the legs.
-
DiaFootCare: a mobile app to help adults with diabetic foot ulcers manage self-care in Oman
A mobile app called DiaFootCare will be tested to see if it helps adults with diabetic foot ulcers in Oman take better care of themselves and improve healing compared with usual care.
-
Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes
This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.
-
SugarVita 2.0: a 12-week digital game for adults with type 2 diabetes
This 12-week pilot tests SugarVita 2.0, a serious digital game, to see if it helps adults with type 2 diabetes manage their condition and feel more confident.
-
Linking social care with healthcare to help manage chronic diseases
This trial tests whether pairing patients with trained community health workers can help them get transportation, healthy food, information, and better access to care to improve health in conditions like hypertension, diabetes, and high cholesterol.
-
Transcutaneous and topical photobiomodulation for diabetic foot ulcers
This phase 2 trial tests whether combining transcutaneous and topical photobiomodulation helps heal foot ulcers in adults with diabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.